A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Single and Multiple AscendingDose Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ICP-488 in Healthy Subjects and Patients With Psoriasis
Epistemonikos ID: 6a2eb7d3f01b8716f24d4f312c4d522ec35f609d
First added on: May 13, 2024